Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCOUNTERPOINT: Weighing the Risks and Benefits of Neoadjuvant Therapy in Resectable Pancreatic Cancer.AuthorsElarre, Pablo Sala; Yu, Kenneth H.SubjectsOXALIPLATIN; THERAPEUTIC use of antimetabolites; ANTIMETABOLITES; PANCREATIC tumors; ADJUVANT treatment of cancer; CANCER relapse; COMBINED modality therapy; DIARRHEA; MEDICAL protocols; PACLITAXEL; TUMOR classification; CHEMORADIOTHERAPY; PROGNOSIS; TUMOR treatment; THERAPEUTICSPublicationOncology (08909091), 2018, Vol 32, Issue 1, p39ISSN0890-9091Publication typeArticle